Anjani, Q.K.; Domínguez-Robles, J.; Utomo, E.; Font, M.; Martínez-Ohárriz, M.C.; Permana, A.D.; Cárcamo-Martínez, Á.; Larrañeta, E.; Donnelly, R.F.
Inclusion Complexes of Rifampicin with Native and Derivatized Cyclodextrins: In Silico Modeling, Formulation, and Characterization. Pharmaceuticals 2022, 15, 20.
https://doi.org/10.3390/ph15010020
AMA Style
Anjani QK, Domínguez-Robles J, Utomo E, Font M, Martínez-Ohárriz MC, Permana AD, Cárcamo-Martínez Á, Larrañeta E, Donnelly RF.
Inclusion Complexes of Rifampicin with Native and Derivatized Cyclodextrins: In Silico Modeling, Formulation, and Characterization. Pharmaceuticals. 2022; 15(1):20.
https://doi.org/10.3390/ph15010020
Chicago/Turabian Style
Anjani, Qonita Kurnia, Juan Domínguez-Robles, Emilia Utomo, María Font, María Cristina Martínez-Ohárriz, Andi Dian Permana, Álvaro Cárcamo-Martínez, Eneko Larrañeta, and Ryan F. Donnelly.
2022. "Inclusion Complexes of Rifampicin with Native and Derivatized Cyclodextrins: In Silico Modeling, Formulation, and Characterization" Pharmaceuticals 15, no. 1: 20.
https://doi.org/10.3390/ph15010020
APA Style
Anjani, Q. K., Domínguez-Robles, J., Utomo, E., Font, M., Martínez-Ohárriz, M. C., Permana, A. D., Cárcamo-Martínez, Á., Larrañeta, E., & Donnelly, R. F.
(2022). Inclusion Complexes of Rifampicin with Native and Derivatized Cyclodextrins: In Silico Modeling, Formulation, and Characterization. Pharmaceuticals, 15(1), 20.
https://doi.org/10.3390/ph15010020